HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2020 | $318 M |
Total: | $318 M |
Period | Weight, tons. |
---|---|
2020 | 4.39 K |
Total: | 4.39 K |
Group product | 2020 | 2020 | Ch. | ∑ (2020-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $17 M | $17 M | 0% | $17 M | 5.3% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | $92.8 M | $92.8 M | 0% | $92.8 M | 29.2% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $208 M | $208 M | 0% | $208 M | 65.5% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $318 M | $318 M | $318 M |
№ | Country | ∑ (2020-2020) | Ratio |
---|---|---|---|
1 | Germany | $2.07 B | 19.1% |
2 | United States | $984 M | 9.1% |
3 | Italy | $800 M | 7.4% |
4 | Switzerland | $792 M | 7.3% |
5 | Ireland | $716 M | 6.6% |
6 | France | $576 M | 5.3% |
7 | India | $507 M | 4.7% |
8 | Slovenia | $318 M | 2.9% |
9 | United Kingdom | $314 M | 2.9% |
10 | Hungary | $297 M | 2.7% |
11 | Netherlands | $289 M | 2.7% |
12 | Austria | $283 M | 2.6% |
13 | China | $272 M | 2.5% |
14 | Spain | $227 M | 2.1% |
15 | Belarus | $223 M | 2.1% |
16 | Puerto Rico | $171 M | 1.6% |
17 | Canada | $154 M | 1.4% |
18 | Belgium | $145 M | 1.3% |
19 | Sweden | $138 M | 1.3% |
20 | Japan | $138 M | 1.3% |
... | ... | ... | ... |
The total for all countries: | $10.8 B | 100% |
№ | Region | ∑ (2020-2020) | Ratio |
---|---|---|---|
1 | Moskovskaya oblast | $194 M | 61.1% |
2 | Moskva | $116 M | 36.5% |
3 | Novosibirskaya oblast | $3.8 M | 1.2% |
4 | Sankt-Peterburg | $3.7 M | 1.2% |
5 | Rostovskaya oblast | $3.13 K | 0% |
By all regions: | $318 M | 100% |